HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Statin-related myotoxicity.

Abstract
Statin therapy has a very important role in decreasing cardiovascular risk, and treatment non-compliance may therefore be a concern in high cardiovascular risk patients. Myotoxicity is a frequent side effect of statin therapy and one of the main causes of statin discontinuation, which limits effective treatment of patients at risk of or with cardiovascular disease. Because of the high proportion of patients on statin treatment and the frequency of statin-related myotoxicity, this is a subject of concern in clinical practice. However, statin-related myotoxicity is probably underestimated because there is not a gold standard definition, and its diagnosis is challenging. Moreover, information about pathophysiology and optimal therapeutic options is scarce. Therefore, this paper reviews the knowledge about the definition, pathophysiology and predisposing conditions, diagnosis and management of statin-related myotoxicity, and provides a practical scheme for its management in clinical practice.
AuthorsVera Fernandes, Maria Joana Santos, Antonio Pérez
JournalEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion (Endocrinol Nutr) Vol. 63 Issue 5 Pg. 239-49 (May 2016) ISSN: 1579-2021 [Electronic] Spain
PMID27005745 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2016 SEEN. Published by Elsevier España, S.L.U. All rights reserved.
Chemical References
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Creatine Kinase
  • Ezetimibe
Topics
  • Clinical Trials as Topic
  • Comorbidity
  • Creatine Kinase (blood)
  • Cytochrome P-450 CYP3A (physiology)
  • Dietary Supplements
  • Disease Management
  • Disease Susceptibility
  • Drug Interactions
  • Drug Substitution
  • Exercise
  • Ezetimibe (therapeutic use)
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects, pharmacology)
  • Incidence
  • Male
  • Meta-Analysis as Topic
  • Muscular Diseases (chemically induced, epidemiology, genetics, physiopathology)
  • Rhabdomyolysis (chemically induced, epidemiology, physiopathology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: